Clinical Trial Update: A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ranibizumab injections in diabetic macular edema; the RISE study results were completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (Lucentis) (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Diabetes Mellitus, Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2013-01-17